Study population
myomas, uterine anomalies, submucous fibroids, thyroid dysfunction, hyperprolactinemia
MYOMAS, DIABETES MELLITUS, THYROID DYSFUNCTION, HYPERPROLACTINEMIA, ENDOCRINE DISORDERS, CHROMOSOMAL ABNORMALITY
A total of 156 patients were recruited for AC-FET. Exclusion criteria included females over 40 years of age or follicle-stimulating hormone (FSH) ≥20IU/L, uterine anomalies, intramural myomas (≥4 cm), submucous fibroids, endometrium thickness less than 7 mm before embryo transfer, patients who had untreated systemic or endocrine disorders such as diabetes mellitus, thyroid dysfunction or hyperprolactinemia and female or male chromosomal abnormality (Flowchart of study design.